dc.contributor.author |
Wilks, Samuel H. |
|
dc.contributor.author |
Mühlemann, Barbara |
|
dc.contributor.author |
Shen, Xiaoying |
|
dc.contributor.author |
Türeli, Sina |
|
dc.contributor.author |
LeGresley, Eric B. |
|
dc.contributor.author |
Netzl, Antonia |
|
dc.contributor.author |
Caniza, Miguela A. |
|
dc.contributor.author |
Chacaltana-Huarcaya, Jesus N. |
|
dc.contributor.author |
Corman, Victor M. |
|
dc.contributor.author |
Daniell, Xiaoju |
|
dc.contributor.author |
Datto, Michael B. |
|
dc.contributor.author |
Dawood, Fatimah S. |
|
dc.contributor.author |
Denny, Thomas N. |
|
dc.contributor.author |
Drosten, Christian |
|
dc.contributor.author |
Fouchier, Ron A. M. |
|
dc.contributor.author |
Garcia Funegra, Patricia Jannet |
|
dc.contributor.author |
Halfmann, Peter J. |
|
dc.contributor.author |
Jassem, Agatha |
|
dc.contributor.author |
Jeworowski, Lara M. |
|
dc.contributor.author |
Jones, Terry C. |
|
dc.contributor.author |
Kawaoka, Yoshihiro |
|
dc.contributor.author |
Krammer, Florian |
|
dc.contributor.author |
McDanal, Charlene |
|
dc.contributor.author |
Pajon, Rolando |
|
dc.contributor.author |
Simon, Viviana |
|
dc.contributor.author |
Stockwell, Melissa S. |
|
dc.contributor.author |
Tang, Haili |
|
dc.contributor.author |
van Bakel, Harm |
|
dc.contributor.author |
Veguilla, Vic |
|
dc.contributor.author |
Webby, Richard |
|
dc.contributor.author |
Montefiori, David C. |
|
dc.contributor.author |
Smith, Derek J. |
|
dc.date.accessioned |
2023-12-05T17:48:01Z |
|
dc.date.available |
2023-12-05T17:48:01Z |
|
dc.date.issued |
2023 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/14643 |
|
dc.description.abstract |
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, multiple variants escaping preexisting immunity emerged, causing reinfections of previously exposed individuals. Here, we used antigenic cartography to analyze patterns of cross-reactivity among 21 variants and 15 groups of human sera obtained after primary infection with 10 different variants or after messenger RNA (mRNA)–1273 or mRNA-1273.351 vaccination. We found antigenic differences among pre-Omicron variants caused by substitutions at spike-protein positions 417, 452, 484, and 501. Quantifying changes in response breadth over time and with additional vaccine doses, our results show the largest increase between 4 weeks and >3 months after a second dose. We found changes in immunodominance of different spike regions, depending on the variant an individual was first exposed to, with implications for variant risk assessment and vaccine-strain selection. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
American Association for the Advancement of Science |
|
dc.relation.ispartofseries |
Science |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
SARS-CoV-2 |
en_US |
dc.subject |
Antigenic |
en_US |
dc.subject |
Serological |
en_US |
dc.subject.mesh |
SARS-CoV-2 |
|
dc.subject.mesh |
Modulación Antigénica |
|
dc.subject.mesh |
Prueba Serológica para COVID-19 |
|
dc.title |
Mapping SARS-CoV-2 antigenic relationships and serological responses |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1126/science.adj0070 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.01.01 |
|
dc.relation.issn |
1095-9203 |
|